comparemela.com

Latest Breaking News On - Analyst recommendations for alnylam pharmaceuticals - Page 5 : comparemela.com

Alnylam Pharmaceuticals' (ALNY) "Outperform" Rating Reiterated at Royal Bank of Canada

Alnylam Pharmaceuticals' (ALNY) "Outperform" Rating Reiterated at Royal Bank of Canada
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
William-blair
Michaelw-bonney
Securities-exchange-commission
Morgan-stanley
Analyst-recommendations-for-alnylam-pharmaceuticals
Panagora-asset-management-inc
Jpmorgan-chase-co
Alnylam-pharmaceuticals-company-profile
Cantor-fitzgerald
Alnylam-pharmaceuticals-price-performance
Great-west-life-assurance-co

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Lowered by The Goldman Sachs Group

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Lowered by The Goldman Sachs Group
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelw-bonney
Alnylam-pharmaceuticals
Harbor-capital-advisors-inc
Morgan-stanley
News-ratings-for-alnylam-pharmaceuticals-daily
Insider-activity-at-alnylam-pharmaceuticals
Nasdaq
Hedge-funds-weigh-in-on-alnylam-pharmaceuticals
Goldman-sachs-group
Alnylam-pharmaceuticals-stock-down
Wells-fargo-company

Needham & Company LLC Reiterates "Buy" Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They currently have a $200.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 33.49% from […]

Canada
Michaelw-bonney
Needham-company
Alnylam-pharmaceuticals
Institutional-investors-weigh-in-on-alnylam-pharmaceuticals
Prelude-capital-management
Alnylam-pharmaceuticals-company-profile
Alnylam-pharmaceuticals-inc
Wells-fargo-company
Royal-bank
Profund-advisors

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $170.00

Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective upped by JPMorgan Chase & Co. from $150.00 to $170.00 in a research report released on Thursday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also issued reports […]

Wellington
New-zealand-general
New-zealand
Michaelw-bonney
William-blair
Wells-fargo-company
Morgan-stanley
Wellington-management-group
Norges-bank
Alnylam-pharmaceuticals
News-ratings-for-alnylam-pharmaceuticals-daily
Alnylam-pharmaceuticals-inc

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Rating of "Moderate Buy" from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Rating of "Moderate Buy" from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Sanfordc-bernstein
Michaelw-bonney
Analyst-recommendations-for-alnylam-pharmaceuticals
V-square-quantitative-management
Insider-transactions-at-alnylam-pharmaceuticals
Alnylam-pharmaceuticals-inc
Capital-advisors-ltd
Nasdaq
Alnylam-pharmaceuticals
Alnylam-pharmaceuticals-company-profile
Kb-financial-partners
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.